Capital Observer
A diary of the thought process behind my investment decisions
Tweaking
I sold some XLV and moved the money into Amgen. This does not change my relatively market neutral positioning.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment